 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Quest Evaluates NGS for Dx; First Entry is Sequencing-Based HIV Tropism Test
July 11, 2012
Quest Evaluates NGS for Dx; First Entry is Sequencing-Based HIV Tropism Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Study Finds Roche's NGS-Based HIV Assay Comparable to TruGene; Company Expects 2014 CE-IVD Approval
January 30, 2013 / Clinical Sequencing News - Clinical Labs Must Navigate Tricky Regulatory Landscape for RUO Sequencing Products
April 11, 2012 / Clinical Sequencing News - Industry Observers Question Myriad's Competitive Advantage as It Looks to Launch NGS Cancer Panel
May 22, 2013 / Clinical Sequencing News - Debate Heats Up on ACMG's Incidental Findings Recommendations
May 22, 2013 / Clinical Sequencing News - Adaptive Bio, Bristol-Myers Squibb Collaborate on Cancer Biomarkers
May 9, 2013 / GenomeWeb Daily News